Acute Pain

Poor posture in surgical care has been long associated with worsened clinician health. It is no different in ophthalmology.

FDA announces 137 new drug approvals in 2018 represents an 11% increase over 2017.

Older patients could benefit from skipping traditional bedrest in favor of an exercise program when hospitalized with an acute illness.

A recent study found that 65% of adult users reported using cannabis for pain relief and 88% of those taking opioid analgesics reported reducing or discontinuing use of medications.

The IB-Stim device uses electrical pulses to stimulate cranial nerves and reduce pain associated with irritable bowel syndrome.

In the LIBERTY 1 study, daily relugolix combination therapy led to a reduction in menstrual blood loss of 84.3% and improvements in pain and quality of life.

A short account of patients I’ve known and not loved over the years.

The FDA’s response noted that the onset and duration of intravenous meloxicam would not meet prescriber expectations for an IV drug.

Pain management protocols for women undergoing C-sections, that include a non-opioid option such as EXPAREL, can help improve pain management and reduce the need for opioids.

Investigators found that the prevalence of asthma in patients with opioid dependence was more than double the national prevalence.

William Lennarz, MD, describes the efforts among those in the specialty to reduce pain and anxiety during children's visits to the emergency room.

The updated software will begin being implemented this month for use with the Prometra Pump System.

Heart patients discharged from the hospital with an opioid prescription were less likely to participate in planned follow-up care than those without prescribed opioids.

Crizanlizumab is being developed to prevent painful and unpredictable vaso-occlusive crises in patients with sickle cell disease.

The FDA has approved 2 new dosages of the pain reliever that combines benzhydrocodone and acetaminophen.

New research finds patients face a higher risk of pneumonia if they are taking opioids. The danger is even more pronounced for patients living with HIV.

The guidance touches on hand hygiene, airway management, environmental disinfection, and IV drug injection recommendations.

Ronald Gentile, MD, and colleagues investigated pain-reduction strategies following intravitreal injections. The results have implications for patient experience, physician ratings, and treatment adherence.

A meta-analysis shows the experimental therapy has favorable benefits for certain aspects of pain, as well as preferrable avenues of administration.

A small study found that ketamine decreased symptoms of depression—investigators studied its effects in combination with the opioid-blocker naltrexone compared to a placebo.

The director of Pain Management and Palliative Care at the Englewood Hospital & Medical Center in Englewood, NJ, explains how analgesics may come to the forefront of pain management care.

How issues with pain in patients with Lyme disease or opioid-induced constipation can be managed in a timely, efficient manner.

The SPRINT endura and extensa are cleared for both chronic and acute pain including post-operative pain and post-traumatic pain.

The FDA accepted the NDA for NKTR-181, a drug with slowed entry into the brain that attenuates the dopamine release underlying euphoria.

Researchers identified 6 types of potentially inappropriate prescriptions, all of which were associated with higher hazards for all-cause mortality, 4 with non-fatal overdose, and 5 with fatal overdose.